CN1176796A - Composite drug for treating vegetative nurve functional disturbance - Google Patents
Composite drug for treating vegetative nurve functional disturbance Download PDFInfo
- Publication number
- CN1176796A CN1176796A CN 96109698 CN96109698A CN1176796A CN 1176796 A CN1176796 A CN 1176796A CN 96109698 CN96109698 CN 96109698 CN 96109698 A CN96109698 A CN 96109698A CN 1176796 A CN1176796 A CN 1176796A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- treatment
- semen
- autonomic nervous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invented medicinal composition for treating functional disorder of autonomic nerve is composed of Radix Bupleuri, Radix Paeoniae Alba, Poria, Radix Glycyrrhizae, Herba Menthae, date, etc. It is prepd. by selecting the components, grounding into powders, compounding according to definite proportion then pelletizing.
Description
The present invention relates to Chinese medicine composition, specifically, be meant a kind of autonomic nervous dysfunction's of being used for the treatment of Chinese medicine composition.
The autonomic nervous dysfunction causes owing to vegetative nerve function has obstacle, and this obstacle medically can't solve so far.So do not have medicine with regard to this disease doctor trained in Western medicine, the traditional Chinese medical science not properly.
The object of the present invention is to provide the neural ball of a kind of autonomic nervous dysfunction's of treatment Chinese medicine composition-regulate.This pharmaceutical composition reaches the purpose of other disease of treatment by the treatment to autonomic nervous dysfunction.
The autonomic nervous dysfunction's of being used for the treatment of provided by the present invention pharmaceutical composition is formed and is comprised Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae, Herba Menthae, Cortex Moutan, Semen Ziziphi Spinosae, Semen Pittospori Glabrati.
Each components in proportions is (parts by weight are represented) in the wherein said Chinese medicine composition:
The set of dispense ratio
Radix Bupleuri 2-4 part;
Radix Angelicae Sinensis 2-4 part;
Rhizoma Atractylodis Macrocephalae 2-4 part;
Radix Paeoniae Alba 2-4 part;
Poria 2-4 part;
Radix Glycyrrhizae 2-4 part;
Herba Menthae 0.5-1 part;
Cortex Moutan 2-4 part;
Semen Ziziphi Spinosae 2-4 part;
Semen Pittospori Glabrati 5-7 part.
The preferred proportion of each composition is (parts by weight are represented) in the wherein said pharmaceutical composition;
The set of dispense ratio
3 parts of Radix Bupleuri;
3 parts of Radix Angelicae Sinensis;
3 parts of the Rhizoma Atractylodis Macrocephalaes;
3 parts of the Radix Paeoniae Albas;
3 parts in Poria;
3 parts in Radix Glycyrrhizae;
0.5 part of Herba Menthae;
3 parts of Cortex Moutans;
3 parts of Semen Ziziphi Spinosaes;
5 parts of Semen Pittospori Glabrati.
The preparation method of treatment provided by the present invention autonomic nervous dysfunction's Chinese medicine composition comprises: press the above-mentioned various components of proportion optimization, it is pulverized also mix homogeneously make pill and get final product.
The autonomic nervous dysfunction's of being used for the treatment of provided by the present invention pharmaceutical composition has the effect of getting rid of autonomic nervous dysfunction, enhancing immunity, and neurotoxin, anaphylatoxin, endocrine toxin, erythrotoxin, infection toxin are had good therapeutical effect.
Chinese medical theory is thought: do not have functional disease just not have the disease of device system property, prevention overweights treatment.Treatment provided by the present invention autonomic nervous dysfunction's Chinese medicine composition is by rational Chinese prescription, nationality autonomic nervous dysfunction's treatment and reaching other treatment of conditions.Wherein can remove neurotoxin, prevention and treatment neuropathy, prevention schizophrenia, the Polyglucan toxin, prevent and treat multiple anaphylactogen (to comprise irritated asthma, bronchial asthma, anaphylaxis diseases such as anaphylaxis emphysema), remove the endocrine toxin, prevention and treatment anorexia nervosa and digestive system disease, eliminate the erythrocytolysis toxin, prevention and treatment anemia and aplastic anemia, eliminate and infect toxin, prevention and treat acute and chronic recurrent infectious disease and (comprise upper respiratory tract infection, Green-Bali syndrome etc.).
Prevention overweights treatment, and the pharmaceutical composition that is used for the treatment of the autonomic nervous dysfunction provided by the present invention as adding a certain amount of Semen Ziziphi Spinosae of another Chinese medicine composition again, acts on then more remarkable when using.Wherein the compositing formula of another Chinese medicine composition is:
The set of dispense ratio
Fructus Quisqualis meat 40-60 part;
Omphalia 40-60 part;
Overgrown with weeds smooth 40-60 part;
Dried Alumen 40-60 part;
Crane wind 40-60 part;
Radix Aucklandiae 40-60 part;
Fructus Toosendan 40-60 part;
Semen Arecae 40-60 part;
Semen Torreyae 40-60 part;
Fructus Toosendan 40-60 part.
Embodiment 1
Press 2 parts of proportion optimization Radix Bupleuri, 2 parts of Radix Angelicae Sinensis, 2 parts of the Rhizoma Atractylodis Macrocephalaes, 2 parts of the Radix Paeoniae Albas, 2 parts in Poria, 2 parts in Radix Glycyrrhizae, 0.5 part of Herba Menthae, 2 parts of Cortex Moutans, 2 parts of Semen Ziziphi Spinosaes, 6 parts of Semen Pittospori Glabrati, it is crushed to fine powder and mix homogeneously is made honeyed pill.
Embodiment 2
Press 4 parts of proportion optimization Radix Bupleuri, 4 parts of Radix Angelicae Sinensis, 4 parts of the Rhizoma Atractylodis Macrocephalaes, 4 parts of the Radix Paeoniae Albas, 4 parts in Poria, 4 parts in Radix Glycyrrhizae, 1 part of Herba Menthae, 4 parts of Cortex Moutans, 4 parts of Semen Ziziphi Spinosaes, 7 parts of Semen Pittospori Glabrati, it is crushed to fine powder and mix homogeneously is made honeyed pill.
Embodiment 3
Press 1 part of proportion optimization Radix Bupleuri, 1 part of Radix Angelicae Sinensis, 1 part of the Rhizoma Atractylodis Macrocephalae, 1 part of the Radix Paeoniae Alba, 1 part in Poria, 1 part in Radix Glycyrrhizae, 0.5 part of Herba Menthae, 1 part of Cortex Moutan, 1 part of Semen Ziziphi Spinosae, 5 parts of Semen Pittospori Glabrati, it is crushed to fine powder and mix homogeneously is made honeyed pill.
Claims (3)
1, a kind of pharmaceutical composition that is used for the treatment of the autonomic nervous dysfunction is wherein formed and is comprised Radix Bupleuri, Radix Angelicae Sinensis, the Rhizoma Atractylodis Macrocephalae, the Radix Paeoniae Alba, Poria, Radix Glycyrrhizae, Herba Menthae, Cortex Moutan, Semen Ziziphi Spinosae, Semen Pittospori Glabrati.
2, the described a kind of pharmaceutical composition for the treatment of the autonomic nervous dysfunction of claim 1, wherein said in each components in proportions be (parts by weight are represented):
The set of dispense ratio
Radix Bupleuri 2-4 part;
Radix Angelicae Sinensis 2-4 part;
Rhizoma Atractylodis Macrocephalae 2-4 part;
Radix Paeoniae Alba 2-4 part;
Poria 2-4 part;
Radix Glycyrrhizae 2-4 part;
Herba Menthae 0.5-1 part;
Cortex Moutan 2-4 part;
Semen Ziziphi Spinosae 2-4 part;
Semen Pittospori Glabrati 5-7 part.
3, the described a kind of pharmaceutical composition that is used for the treatment of the autonomic nervous dysfunction of claim 1, wherein said each components in proportions is (parts by weight are represented):
The set of dispense ratio
3 parts of Radix Bupleuri;
3 parts of Radix Angelicae Sinensis;
3 parts of the Rhizoma Atractylodis Macrocephalaes;
3 parts of the Radix Paeoniae Albas;
3 parts in Poria;
3 parts in Radix Glycyrrhizae;
0.5 part of Herba Menthae;
3 parts of Cortex Moutans;
3 parts of Semen Ziziphi Spinosaes;
5 parts of Semen Pittospori Glabrati.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96109698 CN1176796A (en) | 1996-09-19 | 1996-09-19 | Composite drug for treating vegetative nurve functional disturbance |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 96109698 CN1176796A (en) | 1996-09-19 | 1996-09-19 | Composite drug for treating vegetative nurve functional disturbance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1176796A true CN1176796A (en) | 1998-03-25 |
Family
ID=5120530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 96109698 Pending CN1176796A (en) | 1996-09-19 | 1996-09-19 | Composite drug for treating vegetative nurve functional disturbance |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1176796A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103948707A (en) * | 2014-05-27 | 2014-07-30 | 刘云杰 | Traditional Chinese medicine for treating restless legs syndrome |
| CN104547637A (en) * | 2014-12-30 | 2015-04-29 | 黎细乐 | Traditional Chinese medicine composition for treating chronic aplastic anemia complicated with pulmonary infection |
| CN104721649A (en) * | 2015-04-15 | 2015-06-24 | 邵明冉 | Traditional Chinese medicine for treating endocrine dyscrasia |
| CN110934984A (en) * | 2020-01-05 | 2020-03-31 | 刘锁奎 | Traditional Chinese medicine composition for treating auditory hallucination |
-
1996
- 1996-09-19 CN CN 96109698 patent/CN1176796A/en active Pending
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103948707A (en) * | 2014-05-27 | 2014-07-30 | 刘云杰 | Traditional Chinese medicine for treating restless legs syndrome |
| CN103948707B (en) * | 2014-05-27 | 2016-03-02 | 刘云杰 | A kind of Chinese medicine for the treatment of restless legs syndrome |
| CN104547637A (en) * | 2014-12-30 | 2015-04-29 | 黎细乐 | Traditional Chinese medicine composition for treating chronic aplastic anemia complicated with pulmonary infection |
| CN104721649A (en) * | 2015-04-15 | 2015-06-24 | 邵明冉 | Traditional Chinese medicine for treating endocrine dyscrasia |
| CN110934984A (en) * | 2020-01-05 | 2020-03-31 | 刘锁奎 | Traditional Chinese medicine composition for treating auditory hallucination |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1506100A (en) | Medicine for treating acute and chronic bronchitis, asthma and pulmonary emphysema | |
| CN1176796A (en) | Composite drug for treating vegetative nurve functional disturbance | |
| CN1879730A (en) | Chinese medicinal composition for preventing and treating baby pig diarrhea, its preparation method and use | |
| CN1317315A (en) | Tendon-comfortable analgesic | |
| CN1156299C (en) | Health-care tea as cigarette companion and its preparation method | |
| CN1084205C (en) | Medicine for treating disease of upper respiratory tract and its preparation | |
| CN1141114C (en) | Tendon-conditioning analgetic | |
| CN1111033C (en) | Psoriasis treating medicine | |
| CN1148970A (en) | Chinese medical composite for curing vegetative nerve functional disturbance | |
| CN1799614A (en) | Chinese traditional medicine composition for treating liver and kidney diseases and preparation method thereof | |
| CN1099876C (en) | Medicine for curing psoriasis | |
| CN1954877A (en) | Chinese medicinal composite for treating ischemic necrosis of femoral head and its preparation method | |
| CN1081042C (en) | Traditional Chinese medicinal composition for stopping drug taking and preparation process thereof | |
| CN1698863A (en) | Chinese medicine preparation for treating hyperosteogeny | |
| CN1377672A (en) | Rheumatic pain killing preparation | |
| CN1161135C (en) | Medicine for curing carcinoma of stomach | |
| CN1158093C (en) | Medicine composition containing yak bone for treating rhenmatism and method for making same | |
| CN1054052C (en) | Comedo-elimination preparation | |
| CN1099875C (en) | Dermatosis treating medicine | |
| CN1593481A (en) | Chinese patent medicine for treating neurasthenia | |
| CN1799598A (en) | Chinese medicinal composition for treating spleen and stomach diseases and preparation method thereof | |
| CN1459310A (en) | Medicine for treating osteoproliferation | |
| CN1265311A (en) | Alopecia treating medicine | |
| CN1340353A (en) | Orally-applied medicine for treating hepatism and its preparing process | |
| CN1167433C (en) | Medicine for treating acne and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |